Ticker

AGIO

Agios Pharmaceuticals, Inc.

10 catalysts on file

AGIO

Agios Pharmaceuticals, Inc.

Approval Confirmed

AQVESME

thalassemia

263d ago Dec 1, 2025

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Catalyst AI-extracted

AQVESME

thalassemia

205d ago Jan 28, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Approval Confirmed

mitapivat

thalassemia

173d ago Mar 1, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Catalyst AI-extracted

Undisclosed program

143d ago ~ Mar 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

AdCom AI-extracted

mitapivat

sickle cell disease

143d ago ~ Mar 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

PDUFA AI-extracted

mitapivat

sickle cell disease

52d ago Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Phase 2 AI-extracted

tebapivat

Sickle Cell Disease

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Phase 1 AI-extracted

AG-236

polycythemia vera

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Phase 1 AI-extracted

AG-181

phenylketonuria

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

AGIO

Agios Pharmaceuticals, Inc.

Phase 3 Confirmed

mitapivat

sickle cell disease

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →